Google sign-in. No card required.
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
Reporting to the Vice President, Global Analytics & Insights, the Executive Director, Global Forecasting will lead the global forecasting function across disease areas and the portfolio, from preclinical and Phase 1 assets through commercialization. The role directly manages three Senior Directors spanning disease area forecasting and portfolio forecasting methods, systems and analytics, and develops the teams and capabilities needed to support an expanding portfolio.
This leader will integrate forecasts and scenarios into a coherent view of opportunity, demand and risk, informing development, lifecycle, investment and commercial decisions. Working with global and regional partners, the Executive Director will establish shared forecasting standards, align priorities and translate uncertainty into clear recommendations for senior leadership. This position is based at our headquarters in Redwood City, CA.
Responsibilities
-
Set the global forecasting strategy, operating model and priorities across early products, later-stage programs and commercial assets. Align resources and delivery with critical business decisions and planning cycles.
-
Directly manage, coach and develop three Senior Directors and their teams. Establish clear accountabilities across disease area forecasting and portfolio methods, systems and analytics; build leadership capacity and manage functional budgets and vendors.
-
Oversee global patient-based, revenue and demand forecasts, integrating regional inputs into a consistent portfolio view. Agree with regional leaders, Finance and Supply Chain the ownership, review and approval of forecasts for each planning purpose. Challenge key assumptions and ensure analytical rigor, with transparent regional perspectives and unresolved differences.
-
Lead forecasting contributions to cross-portfolio scenario planning with Disease Area Insights and Data & Analytics. Assess overlapping populations, treatment sequencing, combinations, launch timing and product interactions to quantify incremental opportunity and avoid double counting.
-
Establish a shared global and regional framework for methodologies, core assumptions, scenarios, documentation and review, agreed with regional forecasting leaders. Ensure meaningful differences are reconciled or clearly explained with evidence and implications for planning, with an agreed process for justified local adaptations.
-
Oversee forecasting model design, methodologies, consolidation logic and analytical requirements. Partner with Data & Analytics and Information Systems on shared data infrastructure and platform delivery. Guide adoption of probabilistic methods, sensitivity analyses and decision frameworks where they improve assessment of uncertainty, interdependencies and decision thresholds.
-
Partner with Finance and Supply Chain to provide forecasts and scenarios for long-range plans, budgets, launch readiness, supply and capacity planning, and ongoing commercial and demand planning. Ensure transparent translation of patient, treatment duration and utilization assumptions into revenue and demand, with clear bridges explaining differences betwee